AF Stroke Prevention – Applying New Guidance in the Real World

Published: 04 September 2024

  • Views:

    Views Icon 1198

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

First presented at ESC 2024, this on-demand programme sees Prof Gregory Lip (University of Liverpool, UK) lead a faculty comprising Prof Elena Arbelo (University of Barcelona, ES), Prof Thorsten Hanke (Asklepios Klinikum Harburg, DE) and Prof Richard Whitlock (McMaster University, CA) review the application of the latest AF guidance in a clinical setting.

 

This case-based programme explores the considerations of risks in the assessment of treatment strategies, the impact of the guidelines on decision-making and the evidence supporting non-pharmacological stroke prevention.

 

Learning Objectives:

  • Recall the risk of ischaemic stroke in AF patients
  • Compare therapeutic efficacy and risk between left atrial appendage closure and oral anticoagulation in atrial fibrillation
  • Review European guideline updates on the use of left atrial appendage closure in atrial fibrillation
  • Summarise the clinical evidence behind non-pharmacological approaches to stroke prevention in atrial fibrillation

 

The live ESC 2024 symposium was CME-accredited, this on-demand version is not.

 

This programme is supported by an unrestricted educational grant from AtriCure Inc.

More from this programme

Part 1

Introduction and Patient Case

Prof Lip provides a brief introduction to the session, before Prof Arbelo presents the case of a patient with severe mitral regurgitation due to mitral valve prolapse, with persistent atrial fibrillation and severe LA enlargement.

1 session
Introduction and Patient Case Watch now

Part 2

Faculty Discussion on Balancing Risk

Prof Lip leads the discussion on balancing risk, with considerations including a surgical approach over transcatheter edge-to-edge repair and the risk of stroke in AF post-surgery.

1 session
Balancing Risk – Faculty Discussion Watch now

Part 3

AF Guideline Updates

Prof Hanke reviews the evolution of the AF guidelines and considers the implications for cardiologists, including the requirement to insist on concomitant AF ablation and peri-procedural left atrial appendage (LAA) closure, to not forget stand alone EP surgery for patients with persistent AF and to not stop oral anticoagulants after surgical LAA closure.

1 session
AF Guideline Updates Watch now

Part 4

Evidence for Non-pharmacological Stroke Prevention

Prof Whitlock considers non-pharmacological stroke prevention, specifically left atrial appendage occlusion during cardiac surgery. He reviews the LAAOS III study, in addition to the multi-centre ATLAAC trial, that commenced early 2024.

1 session
Evidence for Non-pharmacological Stroke Prevention Watch now

Part 5

Patient Case Revisited, Faculty Discussion and Close

Prof Arbelo revisits the patient case in context of the 2024 ESC guideline recommendations for surgical left atrial appendage occlusion. Prof Lip leads a faculty discussion and moderates audience questions.

1 session
Patient Case Revisited, Faculty Discussion and Close Watch now

Faculty Biographies

Thorsten Hanke

Thorsten Hanke

Thorsten Hanke is Associate Director of the Cardiac Surgery Clinic at the Asklepios Clinic Hamburg-Harburg, Germany. He is specialised in treating atrial fibrillation surgically and inaugurated a surgical stand-alone LAA treatment program at the Cardiac Surgery Clinic in Harburg in 2016. He is the head of the steering committee of the German Surgical ablation registry (CASE-AF), which started in 2016 and which oversees over 400 patients after surgical ablation and LAA treatment.

View full profile